Kathryn Bobb

2.2k total citations · 1 hit paper
13 papers, 1.7k citations indexed

About

Kathryn Bobb is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Kathryn Bobb has authored 13 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Cancer Research. Recurrent topics in Kathryn Bobb's work include NF-κB Signaling Pathways (4 papers), T-cell and Retrovirus Studies (2 papers) and HIV Research and Treatment (2 papers). Kathryn Bobb is often cited by papers focused on NF-κB Signaling Pathways (4 papers), T-cell and Retrovirus Studies (2 papers) and HIV Research and Treatment (2 papers). Kathryn Bobb collaborates with scholars based in United States, United Kingdom and Sweden. Kathryn Bobb's co-authors include Anirvan Ghosh, Shu-Ching Hu, Perry B. Shieh, Tõnis Timmusk, Gulayse Ince-Dunn, Hiroyuki Aizawa, Inga Gurevich, Mitra Cowan, Karthik Balakrishnan and Timothy Fouts and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Neuron.

In The Last Decade

Kathryn Bobb

13 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Signaling Pathway Involved in Calcium Regulation of BDNF Expression

1998 610 citations Perry B. Shieh, Shu-Ching Hu et al. Neuron profile →

Peers

Countries citing papers authored by Kathryn Bobb

Since Specialization

Citations

This map shows the geographic impact of Kathryn Bobb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Bobb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Bobb more than expected).

Fields of papers citing papers by Kathryn Bobb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Bobb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Bobb. The network helps show where Kathryn Bobb may publish in the future.

Co-authorship network of co-authors of Kathryn Bobb

This figure shows the co-authorship network connecting the top 25 collaborators of Kathryn Bobb. A scholar is included among the top collaborators of Kathryn Bobb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathryn Bobb. Kathryn Bobb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus 2021 ·npj Vaccines ·Thomas W. Geisbert, Kathryn Bobb, Viktoriya Borisevich, Joan B. Geisbert, Krystle N. Agans, Robert W. Cross, Abhishek N. Prasad, Karla A. Fenton, Hao Yu, Timothy Fouts, Christopher C. Broder, Antony S. Dimitrov	56
2	NF-κB-Activating Complex Engaged in Response to EGFR Oncogene Inhibition Drives Tumor Cell Survival and Residual Disease in Lung Cancer 2015 ·Cell Reports ·Collin M. Blakely, Evangelos Pazarentzos, Victor Olivas, Saurabh Asthana, Jenny Yan, Irena Tan, Gorjan Hrustanovic, Elton Chan, Luping Lin, Dana S. Neel, W. H. Newton, Kathryn Bobb, Timothy Fouts, Jeffrey Meshulam, Matthew A. Gubens, David M. Jablons, Jeffrey R. Johnson, Sourav Bandyopadhyay, Nevan J. Krogan, Trever G. Bivona	143
3	Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma 2012 ·Clinical Cancer Research ·Claire Fabre, Naoya Mimura, Kathryn Bobb, Sun‐Young Kong, Güllü Görgün, Diana Cirstea, Yiguo Hu, Jiro Minami, Hiroto Ohguchi, Jie Zhang, Jeffrey Meshulam, Ruben D. Carrasco, Yu‐Tzu Tai, Paul G. Richardson, Teru Hideshima, Kenneth C. Anderson	66
4	PBS-1086, a Rel Inhibitor of NF-κB, Ameliorates Collagen-Induced Arthritis in Mice 2012 ·European Journal of Inflammation ·Daniela Impellizzeri, Emanuela Mazzon, Rosanna Di Paola, Maria Galuppo, Placido Bramanti, (unknown), Kathryn Bobb, Dileep D. Monie, Jeffrey Meshulam, Drago R. Sliskovic, Salvatore Cuzzocrea	5
5	P B S-1086, a “Pan-Rel” Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells 2012 ·Blood ·Susan J. Tudhope, Evan A. Mulligan, Jill V. Hunter, Geoffrey Summerfield, Scott Marshall, Jonathan P. Wallis, Helen Marr, Paul Evans, (unknown), Barbara W. Durkacz, Jie Zhang, Jeffrey Meshulam, Kathryn Bobb, Elaine Willmore	2
6	NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis 2011 ·Retrovirology ·(unknown), Unsong Oh, Dibyadeep Datta, Richard V. Turner, Kathryn Bobb, Dileep D. Monie, Drago R. Sliskovic, Jie Zhang, Jeffrey Meshulam, Steven Jacobson	2
7	Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I–associated neurologic disease 2011 ·Blood ·Unsong Oh, (unknown), Dibyadeep Datta, Richard V. Turner, Kathryn Bobb, Dileep D. Monie, Drago R. Sliskovic, Yuetsu Tanaka, Jie Zhang, Jeffrey Meshulam, Steven Jacobson	13
8	Antigenic Comparison of HIV Envelope Complexes Containing Either sCD4, Human Anti-envelope Monoclonal Antibody A32, or CD4 Mimic Protein CD4M9 2005 ·Retrovirology ·(unknown), Kathryn Bobb, (unknown), James E. Robinson, Anthony L. DeVico, Timothy Fouts	1
9	Dendrite Development Regulated by CREST, a Calcium-Regulated Transcriptional Activator 2004 ·Science ·Hiroyuki Aizawa, Shu-Ching Hu, Kathryn Bobb, Karthik Balakrishnan, Gulayse Ince-Dunn, Inga Gurevich, Mitra Cowan, Anirvan Ghosh	214
10	Crosslinked HIV-1 envelope–CD4 receptor complexes elicit broadly cross-reactive neutralizing antibodies in rhesus macaques 2002 ·Proceedings of the National Academy of Sciences ·Timothy Fouts, (unknown), Kathryn Bobb, David C. Montefiori, Carl V. Hanson, V. S. Kalyanaraman, Anthony L. DeVico, Ranajit Pal	92
11	Aromatic amino acids in region 2.3 of Escherichia coli sigma 70 participate collectively in the formation of an RNA polymerase-promoter open complex 2000 ·Journal of Molecular Biology ·Gianina Panaghie, Sarah E. Aiyar, Kathryn Bobb, Richard S. Hayward, Pieter L. De Haseth	84
12	Identification of a Signaling Pathway Involved in Calcium Regulation of BDNF Expression breakdown → 1998 ·Neuron ·Perry B. Shieh, Shu-Ching Hu, Kathryn Bobb, Tõnis Timmusk, Anirvan Ghosh	610
13	Regulation of Dendritic Growth and Remodeling by Rho, Rac, and Cdc42 1997 ·Neuron ·(unknown), Kathryn Bobb, Anirvan Ghosh	436

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact